Neuland Laboratories Limited (NEULANDLAB)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
1024.8
3.25(0.32%)

Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was incorporated in 1984 and is headquartered in Hyderabad, India.

Pricing Updates

TODAY'S HIGH

1039.55

TODAY'S LOW

1019.95

52 WEEK HIGH

2309

52 WEEK LOW

994.55

Major Holders

% of Shares Held by
All Insider

27.84%

% of Shares Held by
Institutions

12.16%

% of Float Held by
Institutions

16.86%

Number of Institutions
Holding Shares

11

Company Overview

MARKET CAP

1316.75 Cr.

ETERPRISE VALUE

1891.45 Cr.

NO. OF SHARES

1.28 Cr.

BOOK VALUE

629.824

DIV. YIELD

None%

DEBT

227.09 Cr.

GROSS PROFIT

378.27 Cr.

CASH

36.65 Cr.

REVENUE

939.96 Cr.

REVENUE/SHARE

732.639

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Investments18.81 Cr.-5.87 Cr.-15.93 Cr.-4.92 Cr.
Change To Liabilities36.64 Cr.-4.72 Cr.-4.79 Cr.38.61 Cr.
Total cashflows from Investing Activities-84.42 Cr.-48.67 Cr.-77.22 Cr.-116.28 Cr.
Net Borrowings-92.19 Cr.23.83 Cr.-87.57 Cr.127.09 Cr.
Total Cash from Financing Activities-113.66 Cr.-5.48 Cr.11.97 Cr.104.84 Cr.
Other Liabilities70.70 Cr.11.94 Cr.6.29 Cr.-26.40 Cr.
Total Assets00124.50 Cr.124.50 Cr.
Net Income80.63 Cr.16.21 Cr.16.44 Cr.12.06 Cr.
Change in Cash-8.76 Cr.3.26 Cr.4.64 Cr.-15.50 Lakhs
Effect of Exchange Rate-4.55 Lakhs8.46 Lakhs-52 k1.46 Lakhs
Total Cash from Operating Activities189.36 Cr.57.34 Cr.69.90 Cr.11.26 Cr.
Depreciation38.39 Cr.30.29 Cr.24.86 Cr.21.34 Cr.
Other Cashflows from Investing Activities2.15 Cr.5.20 Cr.1.44 Cr.1.01 Cr.
Dividends Paid-2.56 Cr.-4.94 Cr.-4.94 Cr.-4.94 Cr.
Change to Inventory-28.06 Cr.-26.89 Cr.-17.56 Cr.-39.97 Cr.
Change to Account Receivables-30.07 Cr.-29.49 Cr.31.53 Cr.-12.25 Cr.
Other Cashflows from Financing Activities-18.89 Cr.-24.36 Cr.-24.95 Cr.-22.24 Cr.
Change to Net Income19.83 Cr.59.02 Cr.12.13 Cr.17.12 Cr.
Capital Expenditures-105.39 Cr.-48.79 Cr.-63.11 Cr.-133.59 Cr.

Financials

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax105.33 Cr.52.92 Cr.20.33 Cr.13.93 Cr.
Minority InterestNoneNoneNoneNone
Net Income109.63 Cr.73.59 Cr.38.44 Cr.29.97 Cr.
Selling General Administrative150.45 Cr.124.23 Cr.113.01 Cr.105.54 Cr.
Gross Profit378.27 Cr.286.23 Cr.224.29 Cr.208.51 Cr.
Ebit109.63 Cr.73.59 Cr.38.44 Cr.29.97 Cr.
Operating Income109.63 Cr.73.59 Cr.38.44 Cr.29.97 Cr.
Other Operating Expenses78.50 Cr.57.12 Cr.46.97 Cr.50.89 Cr.
Interest Expense-11.82 Cr.-16.15 Cr.-9.91 Cr.-13.05 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense24.70 Cr.36.71 Cr.3.89 Cr.1.87 Cr.
Total Revenue936.96 Cr.764.02 Cr.667.45 Cr.528.37 Cr.
Total Operating Expenses827.33 Cr.690.42 Cr.629 Cr.498.40 Cr.
Cost of Revenue558.69 Cr.477.79 Cr.443.15 Cr.319.86 Cr.
Total Other Income Expense Net-4.29 Cr.-20.67 Cr.-18.11 Cr.-16.04 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.80.63 Cr.16.21 Cr.16.44 Cr.12.06 Cr.
Net Income Applicable to Common Shares80.63 Cr.16.21 Cr.16.44 Cr.12.06 Cr.

Balance Sheet

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Intangible Assets3.49 Cr.1.95 Cr.1.80 Cr.1.78 Cr.
Capital Surplus497.77 Cr.497.77 Cr.497.77 Cr.66.36 Cr.
Total Liabilities538.32 Cr.521.02 Cr.431.04 Cr.513.35 Cr.
Stock Holder Equity786.45 Cr.709.95 Cr.699.30 Cr.558.04 Cr.
Minority Interest0000
Other Liabilities83.70 Cr.31.04 Cr.21.79 Cr.14.45 Cr.
Total Assets1324.78 Cr.1230.97 Cr.1130.35 Cr.1071.39 Cr.
Common Stock12.82 Cr.12.82 Cr.12.82 Cr.8.88 Cr.
Retained Earnings276.05 Cr.197.99 Cr.186.90 Cr.170.46 Cr.
Other Liabilities72.10 Cr.83.43 Cr.43.34 Cr.42.93 Cr.
Good Will279.46 Cr.279.46 Cr.279.46 Cr.279.46 Cr.
Treasury Stock-20.08 Lakhs1.36 Cr.1.79 Cr.312.33 Cr.
Other Assets60.57 Cr.65.62 Cr.60.31 Cr.52.69 Cr.
Cash2.43 Cr.11.20 Cr.7.93 Cr.3.28 Cr.
Current Liabilities368.51 Cr.357.63 Cr.326.98 Cr.366.92 Cr.
Long Term Asset Charges0000
Short Long Term Debt25.05 Cr.14.04 Cr.21.68 Cr.16.51 Cr.
Other Stockholder Equity-20.08 Lakhs1.36 Cr.1.79 Cr.312.33 Cr.
Property Plant Equipment431.22 Cr.365.09 Cr.334.89 Cr.289.85 Cr.
Total Cur. Assets549.58 Cr.515.18 Cr.453.47 Cr.447.19 Cr.
Long Term Investments44 Lakhs3.65 Cr.39.92 Lakhs40.02 Lakhs
Net Tangible Assets503.49 Cr.428.53 Cr.418.03 Cr.276.79 Cr.
Short Term Investments6.45 Cr.7.50 Cr.7.50 Cr.7.50 Cr.
Net Receivables222.32 Cr.200.46 Cr.177.93 Cr.205.27 Cr.
Long Term Debt88.13 Cr.77.37 Cr.60.71 Cr.103.48 Cr.
Inventory247.60 Cr.219.54 Cr.192.65 Cr.175.08 Cr.
Accounts Payable152.13 Cr.115.56 Cr.119.68 Cr.124.29 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account